19 completed, 9 unknown, 3 enrolling by invitation, 3 not yet recruiting. 37 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 37 | Completed 19, Unknown 9, Enrolling by invitation 3, Not yet recruiting 3, Active not recruiting 1, Terminated 1, Withdrawn 1 |
Follow Mild Cognitive Impairment: new trials by email Literature Review of Mild Cognitive Impairment trials Research Report on Mild Cognitive Impairment
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Ginkgo Biloba on Blood Biomarkers in Mild Cognitive Impairment Ginkgo Biloba Extract 240 mg, Placebo - Mild Cognitive Impairment, Alzheimer's Disease | Phase 4 | Not yet recruiting | Hanyang University | 120 | 2026-06-01 | 2026-06-26 |
| Light and Sleep Fragmentation Light therapy - Sleep, Mild Cognitive Impairment | Phase 4 | Not yet recruiting | Stanford University | 120 | 2026-06-01 | 2023-08-25 |
| Health Benefits of Nutraceutical Supplementation in Older Adults. Powder containing whey isolate and herbal extracts (30g sachet) - Age-related Functional Decline, Mild Cognitive Impairment | Phase 4 | Completed | GPLIFE HEALTHCARE PRIVATE LIMITED | 23 | 2025-12-24 | 2026-04-16 |
| Improvement of Fish Oil in Obesity With Mild Cognitive Impairment Fish oil intervention, Placebo intervention - Obesity, Mild Cognitive Impairment | Phase 4 | Not yet recruiting | Weiwei Ma | 88 | 2025-08-01 | 2025-06-17 |
| MIBG in Aging and Neurologic Disorders meta-iodobenzylguanidine (MIBG) (123I), 123I-MIBG scintigraphy - Lewy Body Disease, Dementia | Phase 4 | Enrolling by invitation | Mayo Clinic | 50 | 2023-05-08 | 2026-07-30 |
| Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Dementia Spironolactone, Placebo - Mild Cognitive Impairment, Alzheimer Disease | Phase 4 | Completed | Emory University | 25 | 2022-09-06 | 2026-10-30 |
| Effects of a Nutraceutic Compound on Cognitive Impairment Placebo oral vial, Choline Bitartrate - Mild Cognitive Impairment | Phase 4 | Completed | Federico II University | 58 | 2022-09-01 | 2024-01-11 |
| Evaluation of Trazodone in OSA-MCI Trazodone, Placebo - Mild Cognitive Impairment, Obstructive Sleep Apnea | Phase 4 | Active not recruiting | Chinese University of Hong Kong | 134 | 2022-05-10 | 2026-01-06 |
| Water-based Activity to Enhance Recall in Veterans: A Randomized Clinical Trial Usual Care, WATER+CT - Mild Cognitive Impairment | Phase 4 | Completed | VA Office of Research and Development | 121 | 2022-01-03 | 2026-09-14 |
| A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment Choline Alfoscerate, Placebo - Mild Cognitive Impairment | Phase 4 | Unknown | Chong Kun Dang Pharmaceutical | 418 | 2021-09-30 | 2021-09-20 |
| The Effects of Cannabidiol and Homotaurine in Patients With Mild Cognitive Impairment Cannabidiol Oil, Homotaurine - Mild Cognitive Impairment | Phase 4 | Unknown | Aristotle University Of Thessaloniki | 90 | 2021-04-01 | 2021-08-26 |
| Early Diagnosis and Early Treatment of Alzheimer's Disease Based on Senile Plaque Imaging Huperzine A, Placebo - Mild Cognitive Impairment, Biomarker | Phase 4 | Unknown | Shanghai Mental Health Center | 300 | 2019-11-01 | 2019-04-16 |
| RCT of Brain Longitudinal Biomarker Study (OPT-Neuro RCT) Aripiprazole Augmentation, Bupropion Augmentation, Switch to bupropion - Depression, Dementia | Phase 4 | Completed | Centre for Addiction and Mental Health | 87 | 2019-08-01 | 2024-11-25 |
| Lithium As a Treatment to Prevent Impairment of Cognition in Elders Lithium Carbonate, Placebo oral capsule - Mild Cognitive Impairment | Phase 4 | Completed | Ariel Gildengers, MD | 83 | 2018-02-02 | 2025-09-11 |
| Efficacy and Safety of 1612 Capsules in aMnestic Mild Cognitive Impairment 1612 capsule, Placebos - Mild Cognitive Impairment | Phase 4 | Withdrawn | Dongzhimen Hospital, Beijing | 2017-01-01 | 2021-03-04 | |
| Genomic Outcomes of Metformin Metformin, Placebo - Coronary Artery Disease, Mild Cognitive Impairment | Phase 4 | Completed | Wake Forest University Health Sciences | 30 | 2016-08-03 | 2023-11-18 |
| Quality Improvement and Practice Based Research in Neurology Using the EMR Listed for each disorder below, up to three drugs per disorder (too many characters to list in this field; see Intervention Description) - Brain Tumors, Epilepsy | Phase 4 | Enrolling by invitation | Endeavor Health | 3300 | 2016-05-01 | 2025-08-24 |
| Evaluation the Effect of Acetyl-L-carnitine in Patients With Mild Cognitive Impairment Accompanied With Chronic Cerebrovascular Disease Acetyl-L-carnitine hydrochloride 500mg, Placebo - Mild Cognitive Impairment | Phase 4 | Unknown | Hanmi Pharmaceutical Company Limited | 636 | 2016-01-26 | 2020-04-21 |
| The Use of Duloxetine for Cognition Improvement in Individuals With Mild Cognitive Impairment Duloxetine, Placebo - Mild Cognitive Impairment, Depression | Phase 4 | Completed | University of North Texas Health Science Center | 19 | 2016-01-01 | 2018-10-11 |
| Efficacy and Safety of Qinggongshoutao Bolus in aMnestic Mild Cognitive Impairment Qinggongshoutao Bolus, Ginkgo Biloba Extract 761, Placebos - Mild Cognitive Impairment, Herbal Medicine Allergy | Phase 4 | Completed | Dongzhimen Hospital, Beijing | 350 | 2015-05-01 | 2018-10-23 |
Showing 20 of 37. Sign in to see all of them.
Cognitive Dysfunction (37) · Alzheimer Disease (7) · Dementia (5) · Depression (3) · Anosmia (2) · Hypothermia (2) · Parkinson Disease (2) · Parkinsonian Disorders (2) · Quadriplegia (2) · REM Sleep Behavior Disorder (2) · Spinal Cord Injuries (2) · Stroke (2) · Brain Concussion (1) · Brain Neoplasms (1) · Cerebrovascular Disorders (1)
Mental Disorders (37) · Cognition Disorders (36) · Neurocognitive Disorders (36) · Nervous System Diseases (18) · Central Nervous System Diseases (16) · Brain Diseases (14) · Neurodegenerative Diseases (10) · Pathological Conditions, Signs and Symptoms (9) · Signs and Symptoms (7) · Tauopathies (7) · Behavior (5) · Dementia (5) · Neurologic Manifestations (5) · Basal Ganglia Diseases (4) · Cardiovascular Diseases (4)
Donepezil (4) · Metformin (3) · Tablets (3) · Ginkgo biloba extract (2) · Lithium Carbonate (2) · Midodrine (2) · 3-Iodobenzylguanidine (1) · 5''-hydroxycannabidiol glucoside (1) · Aripiprazole (1) · Atropine (1) · Bupropion (1) · Cannabidiol (1) · Cellulose (1) · Choline (1) · Citalopram (1)
New York State Psychiatric Institute (3) · Dongzhimen Hospital, Beijing (2) · James J. Peters Veterans Affairs Medical Center (2) · Mayo Clinic (2) · Ariel Gildengers, MD (1) · Aristotle University Of Thessaloniki (1) · Central Arkansas Veterans Healthcare System (1) · Centre for Addiction and Mental Health (1) · Charite University, Berlin, Germany (1) · Chinese University of Hong Kong (1) · Chong Kun Dang Pharmaceutical (1) · Eisai Inc. (1) · Emory University (1) · Endeavor Health (1) · Federico II University (1)
United States (18) · China (4) · Germany (2) · South Korea (2) · Canada (1) · Croatia (1) · Greece (1) · Hong Kong (1) · India (1) · Italy (1) · Netherlands (1) · Singapore (1) · Switzerland (1)
Bradley Boeve, MD (2) · Davangere Devanand, M.D. (2) · Jinzhou Tian, M.D,PhD (2) · John P Handrakis, PT, DPT, EdD (2) · Anita Murthy (1) · Anke Sambeth, Dr. (1) · Antoine Trammell, MD, MPH (1) · Ariel Gildengers, MD (1) · Aristotle Voineskos, MD (1) · Caterina Breitenstein, PhD (1) · Daniel Weintraub, MD (1) · Davangere Devanand, MD (1) · Gregory Pelton, M.D. (1) · Gregory Pelton, MD (1) · Isabella Heuser, MD, PhD (1)
PMID 16469995, PMID 17060562, PMID 18611150, PMID 20040554, PMID 22090468, PMID 23001939, PMID 24315979, PMID 25531297, PMID 25733639, PMID 29331848, PMID 29560382, PMID 30037778, PMID 32198310, PMID 32333591, PMID 33348363, PMID 33408148, PMID 33422890, PMID 36659633, PMID 36844148, PMID 40501510, PMID 41770546, PMID 8323999
2014 (1), I01RX003143 (1), R01AG040093 (1), R01AG041795 (1), R01AG055389 (1), R01MH114966 (1), R01MH114970 (1), R01MH114980 (1), R01MH114981 (1)